天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> journal list >> PLoS ONE >>article
PLoS ONE

PLoS ONE

IF: 2.89
Download PDF

Broader and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid across twelve primary human cell-based disease systems

Published:26 May 2022 DOI: 10.1371/journal.pone.0268778
Stephanie K Venn-Watson,?Camden N Butterworth

Abstract

A growing body of evidence supports that pentadecanoic acid (C15:0), an odd-chain saturated fat found in butter, is an essential fatty acid that is necessary in the diet to support long-term metabolic and heart health. Here, dose dependent and clinically relevant cell-based activities of pure C15:0 (FA15TM) were compared to eicosapentaenoic acid (EPA), a leading omega-3 fatty acid, as well as to an additional 4,500 compounds. These studies included 148 clinically relevant biomarkers measured across 12 primary human cell systems, mimicking various disease states, that were treated with C15:0 at four different concentrations (1.9 to 50 μM) and compared to non-treated control systems. C15:0 was non-cytotoxic at all concentrations and had dose dependent, broad anti-inflammatory and antiproliferative activities involving 36 biomarkers across 10 systems. In contrast, EPA was cytotoxic to four cell systems at 50 μM. While 12 clinically relevant activities were shared between C15:0 and EPA at 17 μM, C15:0 had an additional 28 clinically relevant activities, especially anti-inflammatory, that were not present in EPA. Further, at 1.9 and 5.6 μM, C15:0 had cell-based properties similar to bupropion (Pearson’s scores of 0.78), a compound commonly used to treat depression and other mood disorders. At 5.6 μM, C15:0 mimicked two antimicrobials, climabazole and clarithromycin (Pearson’s scores of 0.76 and 0.75, respectively), and at 50 μM, C15:0 activities matched that of two common anti-cancer therapeutics, gemcitabine and paclitaxel (Pearson’s scores of 0.77 and 0.74, respectively). In summary, C15:0 had dose-dependent and clinically relevant activities across numerous human cell-based systems that were broader and safer than EPA, and C15:0 activities paralleled common therapeutics for mood disorders, microbial infections, and cancer. These studies further support the emerging role of C15:0 as an essential fatty acid.

Substances (8)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Paclitaxel 33069-62-4 C47H51NO14 1116 suppliers $30.00-$4200.00
Clarithromycin 81103-11-9 C38H69NO13 798 suppliers $5.00-$3300.00
Gemcitabine 95058-81-4 C9H11F2N3O4 589 suppliers $6.00-$6080.00
Climbazole 38083-17-9 C15H17ClN2O2 497 suppliers $14.00-$1593.90
PUROMYCIN DIHYDROCHLORIDE 58-58-2 C22H30ClN7O5 301 suppliers $11.00-$5076.00
Pentadecanoic acid 1002-84-2 C15H30O2 278 suppliers $17.00-$1008.00
3-HYDROXY-2-NAPHTHOIC ACID HYDRAZIDE 5341-58-2 C11H10N2O2 166 suppliers $10.00-$1155.00
EPA 25378-27-2 C20H30O2 44 suppliers $29.00-$558.00

Similar articles